Your browser is no longer supported. Please, upgrade your browser.
Settings
PKI [NYSE]
PerkinElmer, Inc.
IndexS&P 500 P/E40.19 EPS (ttm)3.70 Insider Own0.10% Shs Outstand111.68M Perf Week-7.04%
Market Cap16.59B Forward P/E17.03 EPS next Y8.72 Insider Trans-42.70% Shs Float111.04M Perf Month2.29%
Income412.20M PEG2.36 EPS next Q2.85 Inst Own94.20% Short Float2.85% Perf Quarter20.42%
Sales3.23B P/S5.13 EPS this Y-2.70% Inst Trans0.59% Short Ratio3.31 Perf Half Y36.28%
Book/sh28.94 P/B5.13 EPS next Y20.85% ROA6.20% Target Price155.06 Perf Year46.73%
Cash/sh2.31 P/C64.21 EPS next 5Y17.00% ROE14.00% 52W Range62.91 - 162.70 Perf YTD3.50%
Dividend0.28 P/FCF32.30 EPS past 5Y7.70% ROI6.50% 52W High-8.73% Beta1.16
Dividend %0.19% Quick Ratio1.00 Sales past 5Y5.20% Gross Margin52.00% 52W Low136.05% ATR4.38
Employees13000 Current Ratio1.30 Sales Q/Q36.40% Oper. Margin17.80% RSI (14)53.30 Volatility3.28% 2.79%
OptionableYes Debt/Eq0.57 EPS Q/Q199.60% Profit Margin12.70% Rel Volume0.48 Prev Close148.52
ShortableYes LT Debt/Eq0.46 EarningsFeb 02 AMC Payout7.50% Avg Volume956.25K Price148.50
Recom2.20 SMA200.89% SMA505.78% SMA20028.60% Volume218,762 Change-0.01%
Jan-07-21Upgrade Wells Fargo Equal Weight → Overweight $175
Dec-02-20Initiated Goldman Buy $160
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $150
Nov-09-20Reiterated Needham Buy $139 → $193
Sep-11-20Upgrade Needham Hold → Buy $139
Jul-29-20Upgrade CFRA Hold → Buy
Jan-08-20Initiated Wells Fargo Equal Weight $105
Jan-07-20Initiated Citigroup Neutral $100
Jan-02-20Upgrade Evercore ISI In-line → Outperform
Nov-15-19Initiated Stifel Buy
Oct-31-19Downgrade Piper Jaffray Overweight → Neutral $104 → $89
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $105
May-30-19Initiated Wolfe Research Peer Perform
Apr-09-19Upgrade Goldman Neutral → Buy $115
Jan-03-19Initiated Needham Hold
Nov-02-18Downgrade Janney Buy → Neutral
Oct-09-18Initiated UBS Neutral
Sep-10-18Reiterated Deutsche Bank Hold $88 → $93
Dec-19-17Upgrade BofA/Merrill Underperform → Neutral
Sep-26-17Resumed Goldman Neutral $67
Jan-19-21 09:16AM  
Jan-18-21 10:08AM  
09:41AM  
06:20AM  
Jan-15-21 10:25AM  
Jan-14-21 09:56AM  
08:15AM  
08:00AM  
Jan-13-21 11:15AM  
Jan-12-21 11:41AM  
Jan-11-21 09:55AM  
09:48AM  
06:10AM  
06:00AM  
Jan-08-21 11:30AM  
Jan-07-21 04:25PM  
12:34PM  
07:00AM  
Jan-06-21 12:43PM  
Jan-05-21 06:55AM  
Dec-24-20 07:47AM  
Dec-21-20 02:14PM  
Dec-17-20 11:30AM  
Dec-16-20 08:00AM  
Dec-12-20 03:44AM  
Dec-11-20 09:43AM  
Dec-09-20 12:00PM  
Dec-08-20 10:44AM  
09:33AM  
Dec-07-20 12:45PM  
12:05PM  
Dec-01-20 11:30AM  
Nov-30-20 10:42AM  
Nov-20-20 12:45PM  
08:12AM  
Nov-17-20 08:13AM  
08:00AM  
Nov-16-20 11:00AM  
Nov-12-20 08:00AM  
Nov-10-20 11:30AM  
07:24AM  
Nov-09-20 09:36AM  
08:00AM  
Nov-06-20 09:32AM  
Nov-05-20 12:20PM  
08:00AM  
Nov-04-20 12:45PM  
11:00AM  
08:00AM  
Nov-02-20 04:35PM  
12:00PM  
02:05AM  
Oct-29-20 04:05PM  
07:56AM  
12:31AM  
Oct-28-20 04:05PM  
03:00PM  
Oct-27-20 08:31AM  
Oct-26-20 08:00AM  
Oct-23-20 11:30AM  
Oct-22-20 04:15PM  
08:58AM  
Oct-21-20 12:32PM  
08:55AM  
Oct-20-20 09:00AM  
Oct-19-20 08:35AM  
Oct-16-20 12:00PM  
Oct-13-20 02:27AM  
Oct-12-20 12:10PM  
10:09AM  
08:55AM  
Oct-09-20 12:45PM  
Oct-07-20 11:30AM  
Sep-29-20 04:39PM  
02:40PM  
Sep-19-20 12:46PM  
Sep-17-20 11:30AM  
Sep-16-20 05:21PM  
Sep-12-20 11:52AM  
Sep-11-20 04:34PM  
01:03PM  
09:38AM  
Sep-09-20 08:32AM  
Sep-04-20 08:00AM  
Sep-01-20 11:30AM  
07:20AM  
Aug-31-20 11:46AM  
Aug-27-20 11:31AM  
08:33AM  
Aug-26-20 04:55PM  
Aug-19-20 04:15PM  
08:35AM  
Aug-18-20 09:24AM  
08:04AM  
Aug-17-20 10:39AM  
09:00AM  
Aug-14-20 07:55AM  
Aug-13-20 08:06AM  
Aug-12-20 01:10PM  
01:09PM  
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophym, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldberg Joel SPlease See RemarksJan 06Option Exercise46.2625,1491,163,26796,924Jan 07 04:33 PM
Goldberg Joel SPlease See RemarksJan 06Sale155.5225,1493,911,18271,775Jan 07 04:33 PM
Goldberg Joel SPlease See RemarksJan 05Option Exercise46.261,15853,56373,293Jan 07 04:33 PM
Singh Prahlad R.Please See RemarksJan 05Option Exercise46.2610,636491,96850,537Jan 07 04:59 PM
Singh Prahlad R.Please See RemarksJan 05Sale150.0010,6361,595,40039,901Jan 07 04:59 PM
Goldberg Joel SPlease See RemarksJan 05Sale152.511,518231,51171,775Jan 07 04:33 PM
Tereau Daniel RPlease See RemarksDec 14Option Exercise81.294,094332,80111,521Dec 15 04:10 PM
Tereau Daniel RPlease See RemarksDec 14Sale146.684,094600,5087,427Dec 15 04:10 PM
Okun AndrewPlease See RemarksNov 06Option Exercise81.296,107496,43816,417Nov 09 04:05 PM
Okun AndrewPlease See RemarksNov 06Sale140.146,107855,83510,310Nov 09 04:05 PM
Mock James MPlease See RemarksOct 02Sale124.415,623699,58427,218Oct 05 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Option Exercise43.0123,3871,005,87595,179Aug 03 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Sale117.8423,3872,755,82571,792Aug 03 04:05 PM
Okun AndrewPlease See RemarksJul 29Option Exercise52.654,699247,40217,009Jul 30 06:42 PM
Okun AndrewPlease See RemarksJul 29Sale120.006,699803,88010,310Jul 30 06:42 PM
Tereau Daniel RPlease See RemarksJun 15Option Exercise43.743,242141,78912,879Jun 16 04:06 PM
Tereau Daniel RPlease See RemarksJun 15Sale95.225,452519,1397,427Jun 16 04:06 PM
Barrett PeterDirectorMay 28Option Exercise42.094,750199,90429,552May 29 04:06 PM
Barrett PeterDirectorMay 28Sale100.117,552756,03822,001May 29 04:06 PM
MICHAS ALEXIS PDirectorFeb 10Option Exercise30.51752,28861,691Feb 11 04:16 PM
MICHAS ALEXIS PDirectorFeb 05Option Exercise30.515,526168,59863,386Feb 06 04:05 PM
MICHAS ALEXIS PDirectorFeb 05Sale96.231,777171,00261,609Feb 06 04:05 PM